Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3B |
| 2 |
Truist Financial
TFC
|
+$1.64B |
| 3 |
Broadcom
AVGO
|
+$1.37B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.25B |
| 5 |
Comcast
CMCSA
|
+$1.09B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
UnitedHealth
UNH
|
+$1.52B |
| 3 |
Coca-Cola
KO
|
+$1.51B |
| 4 |
Texas Instruments
TXN
|
+$1.09B |
| 5 |
Ross Stores
ROST
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.93% |
| 2 | Healthcare | 18.46% |
| 3 | Communication Services | 14.42% |
| 4 | Financials | 11.83% |
| 5 | Industrials | 9.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Cousins Properties
CUZ
$4.91B
| $17.5M | 0.01% |
599,532
+72,800
| +14% | +$2.7M |
|
327
Credicorp
BAP
$29.7B
| $17.5M | 0.01% |
122,200
| – | – |
|
|
CVA
328
DELISTED
Covanta Holding Corporation
CVA
| $17.3M | 0.01% |
2,019,800
| – | – |
|
|
RVNC
329
DELISTED
Revance Therapeutics, Inc.
RVNC
| $17.2M | 0.01% |
1,161,900
| – | – |
|
330
Phreesia
PHR
$762M
| $16.2M | 0.01% |
768,500
+368,500
| +92% | +$10.1M |
|
331
Yeti Holdings
YETI
$3.37B
| $15.2M | 0.01% |
780,700
+336,564
| +76% | +$9.98M |
|
332
Newell Brands
NWL
$2.66B
| $15.1M | 0.01% |
1,137,800
-587,200
| -34% | -$10.1M |
|
|
OCFT
333
DELISTED
OneConnect Financial Technology
OCFT
| $14.9M | 0.01% |
146,613
+10,743
| +8% | +$1.33M |
|
334
Yext
YEXT
$580M
| $14.8M | 0.01% |
1,454,400
| – | – |
|
335
Cactus
WHD
$5.79B
| $14.5M | 0.01% |
1,249,900
| – | – |
|
336
Sarepta Therapeutics
SRPT
$1.93B
| $14.2M | 0.01% |
+144,728
| New | +$16.5M |
|
337
Wyndham Hotels & Resorts
WH
$5.49B
| $14.1M | 0.01% |
446,900
-1,345,579
| -75% | -$68.4M |
|
338
Flex
FLEX
$46.5B
| $13.9M | 0.01% |
2,202,157
| – | – |
|
339
Evertec
EVTC
$1.86B
| $13.6M | 0.01% |
599,690
+200,390
| +50% | +$6.14M |
|
340
Pool Corp
POOL
$7.23B
| $13.6M | 0.01% |
68,900
-78,100
| -53% | -$16.6M |
|
341
KT
KT
$9.08B
| $13.4M | 0.01% |
1,728,807
+2,024
| +0.1% | +$20.1K |
|
|
CLLS
342
Cellectis
CLLS
$320M
| $12.9M | 0.01% |
1,405,236
+389,300
| +38% | +$5.81M |
|
|
PPL
343
PPL Corp
PPL
$26.8B
| $12.9M | 0.01% |
523,133
| – | – |
|
344
Fair Isaac
FICO
$22.8B
| $12.8M | 0.01% |
41,700
-88,875
| -68% | -$32.7M |
|
345
UBS Group
UBS
$175B
| $12.6M | 0.01% |
1,343,666
| – | – |
|
346
Xenon Pharmaceuticals
XENE
$6.19B
| $12M | ﹤0.01% |
1,055,726
| – | – |
|
347
Endava
DAVA
$161M
| $11.3M | ﹤0.01% |
322,200
| – | – |
|
|
PPLI
348
People Inc
PPLI
$2.99B
| $10.8M | ﹤0.01% |
335,724
-1,643,372
| -83% | -$65.1M |
|
|
NLSN
349
DELISTED
Nielsen Holdings plc
NLSN
| $10.7M | ﹤0.01% |
856,400
| – | – |
|
|
SILK
350
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $10.1M | ﹤0.01% |
+320,600
| New | +$12.8M |
|
Similar funds
Capital International Investors's Q1 2020 Portfolio in Review
As of Q1 2020, Capital International Investors held 436 positions worth $245B, down 17% from $294B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Capital International Investors deployed $11B of net new capital in Q1 2020, opening 44 new positions and adding to 185 existing holdings. Its largest new stake was Travelers Companies: 3,899,590 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Intel, an estimated $1.59B trimmed.
- Capital International Investors's largest Q1 2020 buy was Travelers Companies: 3,899,590 shares worth $387M.
- Capital International Investors added most to Gilead Sciences in Q1 2020, an estimated $3B increase.
- Capital International Investors's biggest Q1 2020 reduction was Intel, cutting an estimated $1.59B.
- Capital International Investors fully exited United Parcel Service in Q1 2020, selling an estimated $586M.
- Capital International Investors's ten largest holdings make up 30% of its $245B portfolio in Q1 2020.
- Capital International Investors opened 44 new positions and closed 36 in Q1 2020.
- Capital International Investors's portfolio value fell 17% quarter-over-quarter to $245B.
Based on Capital International Investors's 13F filing for Q1 2020, filed 15 May 2020.